Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2009

01-05-2009 | Brief Report

A dramatic increase of Yersinia enterocolitica serogroup O:8 infections in Poland

Authors: W. Rastawicki, J. Szych, R. Gierczyński, N. Rokosz

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2009

Login to get access

Excerpt

Yersinia enterocolitica and Y. pseudotuberculosis have been reported as a cause of gastroenteritis and mesenteric lymphadenitis. Sometimes, a Yersinia infection is suspected on the basis of postinfectious complications, such as reactive arthritis or erythema nodosum, after an infection which has mostly passed unnoticed [1]. Different pathogenic serogroups of Y. enterocolitica are found in different parts of the world. For many years, serogroups O:3 and O:9 were predominant in Europe, while Y. enterocolitica serogroup O:8, biotype 1B was the most prevalent serogroup in the USA [1]. Nowadays, in North America, the epidemiological pattern of Y. enterocolitica infections has changed, and serogroup O:3, biotype 4 is now predominant, like in other parts of the world [1, 2]. …
Literature
1.
go back to reference Bottone EJ (1997) Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 10:257–276PubMed Bottone EJ (1997) Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 10:257–276PubMed
2.
go back to reference Lee LA, Taylor J, Carter GP, Quinn B, Farmer JJ 3rd, Tauxe RV (1991) Yersinia enterocolitica O:3: an emerging cause of pediatric gastroenteritis in the United States. The Yersinia enterocolitica Collaborative Study Group. J Infect Dis 163:660–663PubMed Lee LA, Taylor J, Carter GP, Quinn B, Farmer JJ 3rd, Tauxe RV (1991) Yersinia enterocolitica O:3: an emerging cause of pediatric gastroenteritis in the United States. The Yersinia enterocolitica Collaborative Study Group. J Infect Dis 163:660–663PubMed
3.
go back to reference Schubert S, Bockemühl J, Brendler U, Heesemann J (2003) First isolation of virulent Yersinia enterocolitica O8, biotype 1B in Germany. Eur J Clin Microbiol Infect Dis 22:66–68PubMed Schubert S, Bockemühl J, Brendler U, Heesemann J (2003) First isolation of virulent Yersinia enterocolitica O8, biotype 1B in Germany. Eur J Clin Microbiol Infect Dis 22:66–68PubMed
4.
go back to reference Martini A, Fantasia M, Raballo A (1989) Yersinia enterocolitica O8 “American strain” isolated in Italy. Microbiologica 12:345–347PubMed Martini A, Fantasia M, Raballo A (1989) Yersinia enterocolitica O8 “American strain” isolated in Italy. Microbiologica 12:345–347PubMed
5.
go back to reference Chiesa C, Pacifico L, Guiyoule A, Ravagnan G, Mollaret HH (1991) Phenotypic characterization and virulence of O8 Yersinia strains isolated in Europe. Contrib Microbiol Immunol 12:182–191PubMed Chiesa C, Pacifico L, Guiyoule A, Ravagnan G, Mollaret HH (1991) Phenotypic characterization and virulence of O8 Yersinia strains isolated in Europe. Contrib Microbiol Immunol 12:182–191PubMed
6.
go back to reference Szych J, Rastawicki W, Gierczyński R, Krygier R, Mądroszyk A, Cieślik A (2004) First isolation of virulent Yersinia enterocolitica O8, biotype 1B in Poland. Post Mikrobiol 43(Suppl 1):159 Szych J, Rastawicki W, Gierczyński R, Krygier R, Mądroszyk A, Cieślik A (2004) First isolation of virulent Yersinia enterocolitica O8, biotype 1B in Poland. Post Mikrobiol 43(Suppl 1):159
7.
go back to reference Suzuki T, Gorzynski EA, Neter E (1964) Separation by ethanol of common and somatic antigens of Enterobacteriaceae. J Bacteriol 88:1240–1243PubMed Suzuki T, Gorzynski EA, Neter E (1964) Separation by ethanol of common and somatic antigens of Enterobacteriaceae. J Bacteriol 88:1240–1243PubMed
8.
go back to reference Heesemann J, Gross U, Schmidt N, Laufs R (1986) Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun 54:561–567PubMed Heesemann J, Gross U, Schmidt N, Laufs R (1986) Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun 54:561–567PubMed
9.
go back to reference Rastawicki W (2008) Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens. Med Dośw Mikrobiol 60:27–37PubMed Rastawicki W (2008) Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens. Med Dośw Mikrobiol 60:27–37PubMed
10.
go back to reference Wauters G, Kandolo K, Janssens M (1987) Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol 9:14–21PubMed Wauters G, Kandolo K, Janssens M (1987) Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol 9:14–21PubMed
11.
go back to reference Gierczyński R, Jagielski M, Rastawicki W (2002) Molecular virulence attributes and occurrence of pYV-bearing strains among human clinical isolates of Yersinia enterocolitica in Poland. Eur J Clin Microbiol Infect Dis 21:158–159PubMedCrossRef Gierczyński R, Jagielski M, Rastawicki W (2002) Molecular virulence attributes and occurrence of pYV-bearing strains among human clinical isolates of Yersinia enterocolitica in Poland. Eur J Clin Microbiol Infect Dis 21:158–159PubMedCrossRef
13.
go back to reference The community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2005 (2006) The EFSA Journal 94:159–165 The community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2005 (2006) The EFSA Journal 94:159–165
Metadata
Title
A dramatic increase of Yersinia enterocolitica serogroup O:8 infections in Poland
Authors
W. Rastawicki
J. Szych
R. Gierczyński
N. Rokosz
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0647-7

Other articles of this Issue 5/2009

European Journal of Clinical Microbiology & Infectious Diseases 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine